1. Home
  2. OI vs BEAM Comparison

OI vs BEAM Comparison

Compare OI & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OI
  • BEAM
  • Stock Information
  • Founded
  • OI 1903
  • BEAM 2017
  • Country
  • OI United States
  • BEAM United States
  • Employees
  • OI N/A
  • BEAM N/A
  • Industry
  • OI Containers/Packaging
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OI Consumer Discretionary
  • BEAM Health Care
  • Exchange
  • OI Nasdaq
  • BEAM Nasdaq
  • Market Cap
  • OI 2.0B
  • BEAM 1.9B
  • IPO Year
  • OI N/A
  • BEAM 2020
  • Fundamental
  • Price
  • OI $13.37
  • BEAM $30.35
  • Analyst Decision
  • OI Buy
  • BEAM Buy
  • Analyst Count
  • OI 8
  • BEAM 11
  • Target Price
  • OI $16.25
  • BEAM $45.90
  • AVG Volume (30 Days)
  • OI 1.7M
  • BEAM 1.2M
  • Earning Date
  • OI 10-29-2024
  • BEAM 11-05-2024
  • Dividend Yield
  • OI N/A
  • BEAM N/A
  • EPS Growth
  • OI N/A
  • BEAM N/A
  • EPS
  • OI N/A
  • BEAM N/A
  • Revenue
  • OI $6,643,000,000.00
  • BEAM $349,643,000.00
  • Revenue This Year
  • OI N/A
  • BEAM N/A
  • Revenue Next Year
  • OI $2.33
  • BEAM $6.04
  • P/E Ratio
  • OI N/A
  • BEAM N/A
  • Revenue Growth
  • OI N/A
  • BEAM 328.73
  • 52 Week Low
  • OI $10.08
  • BEAM $18.85
  • 52 Week High
  • OI $17.58
  • BEAM $49.50
  • Technical
  • Relative Strength Index (RSI)
  • OI 60.67
  • BEAM 72.41
  • Support Level
  • OI $11.07
  • BEAM $21.46
  • Resistance Level
  • OI $13.08
  • BEAM $27.30
  • Average True Range (ATR)
  • OI 0.47
  • BEAM 1.64
  • MACD
  • OI 0.14
  • BEAM 0.78
  • Stochastic Oscillator
  • OI 95.63
  • BEAM 82.76

About OI O-I Glass Inc.

O-I Glass is the world's largest manufacturer of glass bottles; 70% of its revenue comes from outside the United States. O-I has a leading position in key markets such as Europe, North America, and Brazil. Beer is the primary end market for O-I's glass bottles, which are also used for wine, soda, spirits, condiments, and food. O-I is looking to maintain or expand its dominant positions in Europe, North America, and South America.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

Share on Social Networks: